1-2 of 2
Mark S. Kaminski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma

Clinical Trials & Observations
W. Richard Burack, Hongli Li, Diana Adlowitz, Janice M. Spence, Lisa M. Rimsza, Mazyar Shadman, Catherine M. Spier, Mark S. Kaminski, John P. Leonard, Michael L. Leblanc, Sonali M. Smith, Jonathan W. Friedberg
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5082–5090.
https://doi.org/10.1182/bloodadvances.2022009467
Published: 2023
Includes: Supplemental data
Journal Articles

Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma

Clinical Trials & Observations
Tycel J. Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa, Philip Boonstra, Tera Lynn Mayer, Victoria Nachar, Ryan A. Wilcox, Shannon A. Carty, Yasmin H. Karimi, Zaneta Nikolovska-Coleska, Mark S. Kaminski, Alex F. Herrera, Kami Maddocks, Leslie Popplewell, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4518–4527.
https://doi.org/10.1182/bloodadvances.2023009992
Published: 2023
Includes: Supplemental data